# GRALISE
> **NDA022544** · New Drug Application · Sponsor: ALMATICA · Approved 2011-01-28
## Drug
- **FDA Application Number:** NDA022544
- **Application type:** New Drug Application
- **Brand name:** GRALISE
- **Generic name:** GABAPENTIN
- **Active ingredients:** GABAPENTIN
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** ALMATICA
- **Manufacturer:** Almatica Pharma LLC
- **First approval:** 2011-01-28
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022544)
---
*AI Analytics · CC0 1.0*